Illumina Inc (NASDAQ:ILMN)

CAPS Rating: 3 out of 5

The Company is a developer, manufacturer and marketer of next-generation life-science tools and integrated systems for the analysis of genetic variation and biological function.

Recs

0
Player Avatar jpriley47 (38.33) Submitted: 6/22/2011 10:55:13 PM : Outperform Start Price: $73.01 ILMN Score: +70.37

Company will profit greatly from increased interest in genomic mapping for various diseases and looking at protein interactions with the genome. Beginning to be the new big thing in research and with a high quality reputation.

Featured Broker Partners


Advertisement